Study Evaluating Renal Cell Carcinoma Risk Factors
This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients na√Øve to renal cell carcinoma (RCC) treatment.
Carcinoma, Renal Cell
OTHER: Epidemiological study according to clinical practice
Progression-free survival, 12 months
Response rate., 12 months|Overall survival., 12 months
invitation to volunteer